review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Robert Lefkowitz | Q80910 |
P2093 | author name string | Jeffrey J Kovacs | |
Makoto R Hara | |||
Jihee Kim | |||
Chandra L Davenport | |||
P2860 | cites work | Arrestins: ubiquitous regulators of cellular signaling pathways | Q21184142 |
Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes | Q22008730 | ||
beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2 | Q22253360 | ||
beta-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins | Q24292014 | ||
A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription | Q24297869 | ||
Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling | Q24299892 | ||
{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase | Q24301549 | ||
Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2 | Q24305064 | ||
Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2 | Q24305533 | ||
A beta-arrestin 2 signaling complex mediates lithium action on behavior | Q24306355 | ||
The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner | Q24308947 | ||
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior | Q24310712 | ||
Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2 | Q24315023 | ||
Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5 | Q24316484 | ||
Functional specialization of beta-arrestin interactions revealed by proteomic analysis | Q24318455 | ||
Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling | Q24320156 | ||
Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor | Q24320318 | ||
The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic receptor recycling and resensitization | Q24323133 | ||
beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation | Q24324243 | ||
Deltex acts as a positive regulator of Notch signaling through interactions with the Notch ankyrin repeats | Q24337414 | ||
Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis | Q24337549 | ||
Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism. | Q48577723 | ||
Arrestin-mediated ERK activation by gonadotropin-releasing hormone receptors: receptor-specific activation mechanisms and compartmentalization. | Q50746717 | ||
Wnt5a promotes adhesion of human dermal fibroblasts by triggering a phosphatidylinositol-3 kinase/Akt signal. | Q51794895 | ||
The left-right determinant Inversin is a component of node monocilia and other 9+0 cilia. | Q52107835 | ||
beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation | Q77452079 | ||
alpha-Thrombin induces rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression | Q77785692 | ||
Arrestin serves as a molecular switch, linking endogenous alpha2-adrenergic receptor to SRC-dependent, but not SRC-independent, ERK activation | Q79815563 | ||
A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation | Q80057802 | ||
Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation | Q83367366 | ||
M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms | Q34767650 | ||
Tgf-beta superfamily signaling in embryonic development and homeostasis | Q34963093 | ||
Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease | Q34982718 | ||
Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization | Q35028704 | ||
Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2 | Q35131741 | ||
IGF type 1 receptor: a cell cycle progression factor that regulates aging. | Q35173474 | ||
Targeting of beta-arrestin2 to the centrosome and primary cilium: role in cell proliferation control | Q28571736 | ||
Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor | Q28572837 | ||
Sonic hedgehog guides axons through a noncanonical, Src-family-kinase-dependent signaling pathway | Q28575061 | ||
Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1. | Q28575441 | ||
{beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation | Q28577649 | ||
Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades | Q28578325 | ||
Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins | Q28578546 | ||
Cilia and Hedgehog responsiveness in the mouse | Q28585101 | ||
Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved | Q28585804 | ||
Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence | Q28590279 | ||
A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis | Q28592370 | ||
Hedgehog signalling in the mouse requires intraflagellar transport proteins | Q28593010 | ||
Loss of the retrograde motor for IFT disrupts localization of Smo to cilia and prevents the expression of both activator and repressor functions of Gli | Q28593401 | ||
The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 | ||
Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms | Q29614613 | ||
WNT and beta-catenin signalling: diseases and therapies | Q29616159 | ||
Specificity and versatility in tgf-beta signaling through Smads | Q29616324 | ||
Beta-arrestins and cell signaling | Q29616793 | ||
Transcriptional control by the TGF-beta/Smad signaling system | Q29618985 | ||
Non-Smad pathways in TGF-beta signaling | Q29620040 | ||
Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2 | Q30486708 | ||
The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42. | Q30487886 | ||
Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells | Q30491381 | ||
Primary cilia are not required for normal canonical Wnt signaling in the mouse embryo. | Q33498502 | ||
Hedgehog signal transduction: from flies to vertebrates | Q33783491 | ||
Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor | Q33819496 | ||
Role of TAK1 and TAB1 in BMP signaling in early Xenopus development | Q33888315 | ||
Stirring up development with the heterotrimeric kinesin KIF3. | Q34156482 | ||
Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors | Q34332448 | ||
Role of beta-arrestin 1 in the metastatic progression of colorectal cancer | Q34335080 | ||
Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization | Q34470011 | ||
Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor | Q34548751 | ||
beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor | Q34562493 | ||
Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins. | Q34564790 | ||
kurtz, a novel nonvisual arrestin, is an essential neural gene in Drosophila | Q34609991 | ||
beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor | Q34754993 | ||
Notch signaling in development and disease | Q35676772 | ||
Signaling in time and space: G protein-coupled receptors and mitogen-activated protein kinases | Q35748162 | ||
Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. | Q35800324 | ||
beta-arrestins: traffic cops of cell signaling | Q35804809 | ||
Seven-transmembrane receptors and ubiquitination | Q35951259 | ||
Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons | Q36184325 | ||
Wnt and calcium signaling: beta-catenin-independent pathways | Q36228742 | ||
A Drosophila nonvisual arrestin is required for the maintenance of olfactory sensitivity. | Q36333860 | ||
Structure-function analysis of Frizzleds | Q36397539 | ||
Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation | Q36411260 | ||
Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells | Q36638807 | ||
New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors | Q36678037 | ||
Physiological roles of G protein-coupled receptor kinases and arrestins | Q36737680 | ||
The IGF-I signaling pathway | Q36754655 | ||
Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. | Q36936400 | ||
Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling. | Q36954117 | ||
Beta-arrestin-mediated localization of smoothened to the primary cilium | Q36983577 | ||
Smoothened signaling in vertebrates is facilitated by a G protein-coupled receptor kinase | Q36992971 | ||
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta | Q37052635 | ||
S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking | Q37070857 | ||
Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways | Q24338654 | ||
Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds | Q24605173 | ||
A molecular mechanism for the effect of lithium on development | Q24629067 | ||
Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways | Q24643003 | ||
Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo | Q24647416 | ||
Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction | Q24653656 | ||
beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice | Q24654027 | ||
The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain | Q24673655 | ||
Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes | Q24685424 | ||
Structure of Vps26B and mapping of its interaction with the retromer protein complex | Q27649357 | ||
The Wnt signaling pathway in development and disease | Q27861019 | ||
Vertebrate Smoothened functions at the primary cilium | Q27919682 | ||
Arrestin-related ubiquitin-ligase adaptors regulate endocytosis and protein turnover at the cell surface. | Q27939550 | ||
Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3 | Q28138462 | ||
Signal transduction by the JNK group of MAP kinases | Q28142592 | ||
The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity | Q28188156 | ||
Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin | Q28190513 | ||
Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4 | Q28205234 | ||
Hedgehog signaling in animal development: paradigms and principles | Q28208463 | ||
Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction | Q28271470 | ||
Beta-arrestin signaling and regulation of transcription | Q28282729 | ||
Proteasome-independent functions of ubiquitin in endocytosis and signaling | Q28282959 | ||
Signaling from Smo to Ci/Gli: conservation and divergence of Hedgehog pathways from Drosophila to vertebrates | Q28285927 | ||
Divergence of hedgehog signal transduction mechanism between Drosophila and mammals | Q28295678 | ||
Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2 | Q28299947 | ||
Cilia and developmental signaling | Q28302606 | ||
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo | Q28504462 | ||
Enhanced morphine analgesia in mice lacking beta-arrestin 2 | Q28504554 | ||
Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates | Q28506652 | ||
The TGF beta activated kinase TAK1 regulates vascular development in vivo | Q28507785 | ||
Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene | Q28507982 | ||
Orpk mouse model of polycystic kidney disease reveals essential role of primary cilia in pancreatic tissue organization | Q28508928 | ||
beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation | Q28512807 | ||
Role of transforming growth factor-beta superfamily signaling pathways in human disease | Q37099520 | ||
Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors. | Q37105461 | ||
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands | Q37210835 | ||
Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer | Q37224229 | ||
The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2. | Q37281661 | ||
The type 1 insulin-like growth factor receptor pathway | Q37300867 | ||
Dampened Hedgehog signaling but normal Wnt signaling in zebrafish without cilia | Q37314322 | ||
G protein Galphai functions immediately downstream of Smoothened in Hedgehog signalling | Q37348019 | ||
Hedgehog signaling in development and cancer. | Q37350250 | ||
The primary cilium coordinates signaling pathways in cell cycle control and migration during development and tissue repair | Q37369347 | ||
The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors | Q37387956 | ||
Wnt signaling pathways meet Rho GTPases. | Q37388913 | ||
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade | Q37416273 | ||
Signal integration by JNK and p38 MAPK pathways in cancer development | Q37560607 | ||
Ryk cooperates with Frizzled 7 to promote Wnt11-mediated endocytosis and is essential for Xenopus laevis convergent extension movements | Q38360630 | ||
Beta-arrestin-mediated signaling regulates protein synthesis. | Q39782848 | ||
Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. | Q39898733 | ||
Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways | Q39924848 | ||
Functional characterization of kurtz, a Drosophila non-visual arrestin, reveals conservation of GPCR desensitization mechanisms. | Q39927110 | ||
A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors | Q39954092 | ||
Beta-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase Ialpha promotes agonist-stimulated sequestration of the beta2-adrenergic receptor | Q39974697 | ||
Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. | Q40065770 | ||
The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells | Q40125606 | ||
Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: role of G-proteins and beta-arrestins | Q40127887 | ||
pVHL and GSK3beta are components of a primary cilium-maintenance signalling network | Q40142798 | ||
Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression | Q40170553 | ||
Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins | Q40175757 | ||
The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling | Q40253140 | ||
Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. | Q40313388 | ||
The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. | Q40463546 | ||
Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells | Q40520944 | ||
Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination | Q40636866 | ||
G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR. | Q40659675 | ||
Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination | Q40672031 | ||
Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation | Q40699131 | ||
Regulation of lysophosphatidic acid receptor-stimulated response by G-protein-coupled receptor kinase-2 and beta-arrestin1 in FRTL-5 rat thyroid cells | Q40720579 | ||
Insulin and insulin-like growth factor I receptors utilize different G protein signaling components | Q40816727 | ||
Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation | Q41177526 | ||
Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation | Q42472178 | ||
Essential role for beta-arrestin 2 in the regulation of Xenopus convergent extension movements | Q42791086 | ||
Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase | Q42798396 | ||
Insulin-induced beta-arrestin1 Ser-412 phosphorylation is a mechanism for desensitization of ERK activation by Galphai-coupled receptors | Q45133871 | ||
Regulation of Notch signalling by non-visual beta-arrestin | Q45345847 | ||
MT1 melatonin receptor internalization underlies melatonin-induced morphologic changes in Chinese hamster ovary cells and these processes are dependent on Gi proteins, MEK 1/2 and microtubule modulation | Q46313463 | ||
Trimeric G protein-dependent frizzled signaling in Drosophila | Q47072581 | ||
Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway | Q47073322 | ||
The effect of pertussis toxin on zebrafish development: a possible role for inhibitory G-proteins in hedgehog signaling | Q48512657 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 16 | |
P304 | page(s) | 443-458 | |
P577 | publication date | 2009-10-01 | |
P1433 | published in | Developmental Cell | Q1524277 |
P1476 | title | Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways | |
P478 | volume | 17 |
Q37065864 | A Significant Role of the Truncated Ghrelin Receptor GHS-R1b in Ghrelin-induced Signaling in Neurons. |
Q35817527 | A negative allosteric modulator demonstrates biased antagonism of the follicle stimulating hormone receptor |
Q28504855 | A novel KRAB domain-containing zinc finger transcription factor ZNF431 directly represses Patched1 transcription |
Q39905040 | A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1. |
Q50299929 | ARRB bind GPCRs |
Q35647525 | Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds |
Q26849316 | Adaptive resistance to targeted therapies in cancer |
Q35545433 | An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease |
Q89454336 | Aptamers: Uptake mechanisms and intracellular applications |
Q34537021 | Arrestin-2 Differentially Regulates PAR4 and ADP Receptor Signaling in Platelets |
Q33992591 | Arrestin-2 interacts with the endosomal sorting complex required for transport machinery to modulate endosomal sorting of CXCR4 |
Q37321957 | Arrestins in host-pathogen interactions |
Q36205804 | Astroglial β-Arrestin1-mediated Nuclear Signaling Regulates the Expansion of Neural Precursor Cells in Adult Hippocampus |
Q33682193 | COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis |
Q34294578 | Caudal genes in blood development and leukemia |
Q53682448 | Controversial Role of Kisspeptins/KiSS-1R Signaling System in Tumor Development. |
Q36776746 | Cross-desensitization and cointernalization of H1 and H2 histamine receptors reveal new insights into histamine signal integration. |
Q37807297 | Current perspectives on the selective regulation of dopamine D2 and D3 receptors |
Q37259213 | Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2 |
Q33903905 | Distinct and shared roles of β-arrestin-1 and β-arrestin-2 on the regulation of C3a receptor signaling in human mast cells |
Q50652866 | Downregulation of β-arrestin 1 suppresses glioblastoma cell malignant progression vis inhibition of Src signaling. |
Q51321708 | Effect of troxerutin on insulin signaling molecules in the gastrocnemius muscle of high fat and sucrose-induced type-2 diabetic adult male rat. |
Q36557104 | Effects of cocaine and withdrawal on the mouse nucleus accumbens transcriptome. |
Q51872392 | Elevated β-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia. |
Q42565864 | Endoplasmic reticulum stress pathway required for immune homeostasis is neurally controlled by arrestin-1. |
Q30415888 | Epigenetic coordination of signaling pathways during the epithelial-mesenchymal transition |
Q37511632 | Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cells |
Q35779157 | Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling |
Q34186022 | Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer. |
Q49462148 | G Protein-Coupled Receptors As Regulators of Localized Translation: The Forgotten Pathway? |
Q37880070 | G Protein-coupled receptor kinase 2 (GRK2): A novel modulator of insulin resistance |
Q37970012 | G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function. |
Q33707710 | GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner |
Q35187043 | Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice |
Q38028547 | Heterodimerisation of G protein-coupled receptors: implications for drug design and ligand screening |
Q34256410 | Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking |
Q35713259 | IQGAP1 and its binding proteins control diverse biological functions |
Q37189430 | Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils |
Q90762243 | Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer |
Q35005851 | Interaction of Arrestin with Enolase1 in Photoreceptors |
Q37809668 | International Union of Basic and Clinical Pharmacology. LXXX. The Class Frizzled Receptors |
Q38053088 | Involvement of β-arrestins in cancer progression |
Q52363961 | Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis. |
Q37232939 | KIF3A binds to β-arrestin for suppressing Wnt/β-catenin signalling independently of primary cilia in lung cancer |
Q35852118 | Long-Acting Beta Agonists Enhance Allergic Airway Disease |
Q41721776 | Loss of β-arrestin-2 and Activation of CXCR2 Correlate with Lymph Node Metastasis in Non-small Cell Lung Cancer |
Q40621763 | Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients |
Q38086019 | Mitogen-Activated Protein (MAP) Kinase Scaffolding Proteins: A Recount. |
Q34488901 | Multiple Scaffolding Functions of β-Arrestins in the Degradation of G Protein-coupled Receptor Kinase 2 |
Q27690729 | Nanobody stabilization of G protein-coupled receptor conformational states. |
Q36505726 | Non-Hematopoietic β-Arrestin1 Confers Protection Against Experimental Colitis. |
Q37869835 | Novel pathways in gonadotropin receptor signaling and biased agonism. |
Q57192334 | Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies |
Q35547856 | Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaine |
Q34581041 | Osteoblast regulation via ligand-activated nuclear trafficking of the oxytocin receptor |
Q35078595 | P2Y(2) receptors and GRK2 are involved in oscillatory fluid flow induced ERK1/2 responses in chondrocytes |
Q28569553 | PAF enhances MMP-2 production in rat aortic VSMCs via a β-arrestin2-dependent ERK signaling pathway |
Q41563028 | PTEN controls glandular morphogenesis through a juxtamembrane β-Arrestin1/ARHGAP21 scaffolding complex |
Q39316276 | Palmitate contributes to insulin resistance through downregulation of the Src-mediated phosphorylation of Akt in C2C12 myotubes |
Q36618617 | Pharmacological blockade of a β(2)AR-β-arrestin-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model |
Q30400167 | Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA1, LPA2, and LPA3. |
Q51754961 | Phosphorylation regulates TRPV1 association with β-arrestin-2. |
Q37761044 | Physiology of the (pro)renin receptor: Wnt of change? |
Q27321217 | Pitchfork and Gprasp2 Target Smoothened to the Primary Cilium for Hedgehog Pathway Activation |
Q35027563 | Regulation of Rho-GEF Rgf3 by the arrestin Art1 in fission yeast cytokinesis |
Q37320596 | Regulation of Toll signaling and inflammation by β-arrestin and the SUMO protease Ulp1. |
Q39131811 | Regulation of inflammation by β-arrestins: Not just receptor tales |
Q28975781 | Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor |
Q53197894 | Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis. |
Q33969519 | Role of glycosylation of Notch in development |
Q33855672 | Role of the Drosophila non-visual ß-arrestin kurtz in hedgehog signalling. |
Q35002768 | SUMOylation attenuates human β-arrestin 2 inhibition of IL-1R/TRAF6 signaling |
Q36647024 | Serotonin receptor signaling and regulation via β-arrestins |
Q37954006 | Setting the clock for recirculating lymphocytes. |
Q36470941 | Signaling organelles of the innate immune system |
Q35972819 | Storage Temperature Alters the Expression of Differentiation-Related Genes in Cultured Oral Keratinocytes |
Q92040403 | Structure-function analysis of β-arrestin Kurtz reveals a critical role of receptor interactions in downregulation of GPCR signaling in vivo |
Q35148896 | Targeted disruption of β-arrestin 2-mediated signaling pathways by aptamer chimeras leads to inhibition of leukemic cell growth |
Q39381430 | The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling |
Q38864897 | The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system |
Q26783047 | The emerging roles of β-arrestins in fibrotic diseases |
Q26801420 | The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence |
Q38188734 | The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin |
Q36670706 | Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling |
Q37309763 | Upregulation of neurovascular communication through filamin abrogation promotes ectopic periventricular neurogenesis |
Q34044736 | β-Arrestin 2 negatively regulates Toll-like receptor 4 (TLR4)-triggered inflammatory signaling via targeting p38 MAPK and interleukin 10. |
Q27325551 | β-Arrestin interacts with the beta/gamma subunits of trimeric G-proteins and dishevelled in the Wnt/Ca(2+) pathway in xenopus gastrulation |
Q34718220 | β-Arrestin mediates oxytocin receptor signaling, which regulates uterine contractility and cellular migration |
Q47425732 | β-Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1/β-catenin signaling in mice |
Q33985855 | β-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice |
Q30448011 | β-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel |
Q38863857 | β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling. |
Q33994385 | β-Arrestin1 promotes the progression of chronic myeloid leukaemia by regulating BCR/ABL H4 acetylation |
Q38902143 | β-Arrestin2 Contributes to Cell Viability and Proliferation via the Down-Regulation of FOXO1 in Castration-Resistant Prostate Cancer |
Q47268946 | β-Arrestin2 mediates progression of murine primary myelofibrosis |
Q36140375 | β-Arrestin2 mediates the initiation and progression of myeloid leukemia. |
Q61315205 | β-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice |
Q36755034 | β-Arrestins Negatively Regulate the Toll Pathway in Shrimp by Preventing Dorsal Translocation and Inhibiting Dorsal Transcriptional Activity |
Q37810522 | β-Arrestins: multifunctional signaling adaptors in type 2 diabetes |
Q64922148 | β-arrestin 1 Overexpression Increases Temozolomide Resistance in Human Malignant Glioma Cells. |
Q35406094 | β-arrestin 2 is associated with multidrug resistance in breast cancer cells through regulating MDR1 gene expression |
Q34540603 | β-arrestin 2-mediated immune suppression induced by chronic stress |
Q24297887 | β-arrestin Kurtz inhibits MAPK and Toll signalling in Drosophila development |
Q42734045 | β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix |
Q44686499 | β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling. |
Q37630356 | β-arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditions |
Search more.